Functional foods and paediatric gastro-intestinal health and disease

Annals of Tropical Paediatrics

Volumn 26, Issue 2, 2006, Pages 79-86

  Taylor, C J ^a,c   Mahenthiralingam, E ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; INULIN; MESALAZINE; OLIGOFRUCTOSE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RNA 16S; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; BACTERIAL DNA; OLIGOSACCHARIDE;

BIOFILM; DISEASE; GASTROENTERITIS; HOMEOSTASIS; IMMUNE SYSTEM;

BIFIDOBACTERIUM; BREAST MILK; CARBOHYDRATE ANALYSIS; CHILDHOOD DISEASE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CROHN DISEASE; CULTURE TECHNIQUE; DENATURING GRADIENT GEL ELECTROPHORESIS; DIARRHEA; DIET SUPPLEMENTATION; ENTERITIS; FLUORESCENCE IN SITU HYBRIDIZATION; FUNCTIONAL FOOD; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MUCOSA; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; ROTAVIRUS; ULCERATIVE COLITIS; VIRUS INFECTION; BACTERIUM; BIOFILM; CHILD; DIET THERAPY; GENE EXPRESSION PROFILING; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MUCOSAL IMMUNITY;

BACTERIA (MICROORGANISMS);

BACTERIA; BIOFILMS; CHILD; DNA, BACTERIAL; GASTROINTESTINAL DISEASES; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; INULIN; OLIGOSACCHARIDES; PROBIOTICS;

EID: 33746206500     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/146532806X107403     Document Type: Review

References (49)

1. Berg RD. The indigenous gastrointestinal micro-flora. Trends Microbiol 1996; 4:430-5.
2. Gustaffson B. The physiological importance of the colonic microflora. Scand J Gastroenterol 1982; 77 (suppl): 117-31.
3. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2001; 2:43-53.
4. Nord CE, Kager L. The normal flora of the gastrointestinal tract. Neth J Med 1984; 27:249-52.
5. Mackowiak PA. The normal microbial flora. N Engl J Med 1982; 307:83-93.
6. Probert HM, Gibson GR. Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol 2002; 3:23-7.
7. Vaughan EE, Heilig HG, Ben-Amor K, de Vos WM. Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev 2005; 29:477-90.
8. Tringe SG, Rubin EM. Metagenomics: DNA sequencing of environmental samples. Nat Rev Genet 2005; 6:805-14.
9. Coenye T, Vandamme P. Extracting phylogenetic information from whole-genome sequencing projects: the lactic acid bacteria as a test case. Microbiology 2003; 149 (pt 12):3507-17.
10. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002; 68:219-26.
11. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 2005; 40:28-37.
12. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-93.
13. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205-11.
14. Qin HL, Shen TY, Gao ZG, iet al. Effect of lactobacillus on the gut microflora and barrier function of rats with abdominal infection. World J Gastroenterol 2005; 11:2591-6.
15. Deitch EA, Winterton J, Berg R. Effect of starvation, malnutrition, and trauma on the gastrointestinal tract flora and bacterial translocation. Arch Surg 1987; 122:1019-24.
16. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 (suppl):S147-71.
17. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microflora: introducing the concept of prebiotics. J Nutr 1995; 125:1401-12.
18. Roberfroid MB. Concepts and strategy of functional food science: the European perspective. Am J Clin Nutr 2000; 71 (suppl): 1660-4S.
19. Holzapfel WH, Haberer P, Geisen R, Bjorkroth J, Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 2001; 73 (2 suppl):365-73S.
20. Coenye T, Vandamme P. Extracting phylogenetic information from whole-genome sequencing projects: the lactic acid bacteria as a test case. Microbiology 2003; 149 (pt 12):3507-17.
21. Yeung PS, Kitts CL, Cano R, Tong PS, Sanders ME. Application of genotypic and phenotypic analyses to commercial probiotic strain identity and relatedness. J Appl Microbiol 2004; 97:1095-104.
22. Hakkarainen J, Toivanen M, Leinonen A, et al. Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro. J Nutr 2005; 135:2445-8.
23. Wold AE, Adlerberth I. Breast feeding and the intestinal microflora of the infant-implications for protection against infectious diseases. Adv Exp Med Biol 2000; 478:77-93.
24. Newburg DS, Peterson JA, Ruiz-Palacios GM, et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998; 351:1160-4.
25. Kvistgaard AS, Pallesen LT, Arias CF, et al. Inhibitory effects of human and bovine milk constituents on rotavirus infections. J Dairy Sci 2004; 87:4088-96.
26. Cucchiara S, Falconieri P, Di Nardo G, Parcelii MA, Dito L, Grandinetti A. New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age. Dig Liver Dis 2002; 34 (suppl 2):S44-7.
27. Salminen S, Isolauri E, Salminen E. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996; 70:347-58.
28. Fedorak RN, Madsen KL. Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 2004; 20:146-55.
29. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol 2004; 78:10213-20.
30. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 1994; 106:65-72.
31. Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999; 134:15-20.
32. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. Br Med J 2001; 322:1327.
33. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138:361-5.
34. Mastretta E, Longo P, Laccisaglia A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002; 35:527-31.
35. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344:1046-9.
36. Bartlett JG. Antibiotic-associated diarrhoea. Clin Infect Dis 1992; 15:573-81.
37. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135:564-8.
38. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002; 16:1461-7.
39. Mattar AF, Drongowski RA, Coran AG, Harmon CM. Effect of probiotics on enterocyte bacterial translocation in vitro. Pediatr Surg Int 2001; 17:265-8.
40. Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 2004; 53:1610-6.
41. Edwards CA, Parrett AM. Dietary fibre in infancy and childhood. Proc Nutr Soc 2003; 62:17-23.
42. Boehm G, Jelinek J, Stahl B, et al. Prebiotics in infant formulas. J Clin Gastroenterol 2004; 38 (6 suppl):S76-9.
43. Shanahan F. Probiotics in inflammatory bowel disease - therapeutic rationale and role. Adv Drug Deliv Rev 2004; 56:809-18.
44. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005; 43:3380-9.
45. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52:975-80.
46. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354:635-9.
47. LGG Multicenter Study Group. A multicenter placebo-controlled, double blind study of Lactobacillus GG in addition to standard maintainance therapy in children with Crohn's disease. J Pediatr Gastroenterol Nutr 2002; 35:406.
48. Guarner F. Inulin and oligofructose: impact on intestinal diseases and disorders. Br J Nutr 2005; 93 (suppl 1):S61-5.
49. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005; 54:242-9.